Pharmafile Logo
Pharmafocus logo
Advanced Search

Allergan navigating choppy waters, as shares rise and fall

March 16, 2018
Medical Communications Allergan, Brent Saunders, biotech, drugs, pharma, pharmaceutical

By most measures Allergan has not had the most successful of years and one measure, in particular, is usually indicative …

News
ears-2545756_960_720

Hearing drug failure puts biotech on brink

March 16, 2018
Medical Communications, Research and Development Auris, biotech, drugs, pharma, pharmaceutical

Biotechs with few products in the portfolio are always at a risk should results come back flat, it often leads …

News
12_rare

The need for flexible appraisal of rare disease medicines

March 15, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amryt Pharma, feature, pharma, rare disease, rare diseases

Recent data has shown that England is, on average, slower than Germany, France, Spain and Italy in making orphan medicinal …

Feature
humacao_exterior

BMS restructure will transfer 90 jobs from NY state to Massachusetts and New Jersey

March 15, 2018
Manufacturing and Production BMS, Bristol-Myers Squibb, Massachusetts, New York, new jersey, pharma

Bristol-Myers Squibb has announced plans to relocate around 90 roles from the state of New York to facilities in Massachusetts …

News
fda_sign_web

Solid Biosciences rocked by clinical hold, shareholders flee

March 15, 2018
Research and Development Solid Biosciences, biotech, drugs, pharma, pharmaceutical

Solid Biosciences raised more than a few eyebrows when it only revealed a partial hold from the FDA stalling its …

News
william_pao

Roche appoints new research and early development head

March 15, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, appointment

Dr John C Reed, Roche’s Head of Pharma Research and Early Development (pRED), is set to leave the company due …

Appointment
obese-3011213_960_720

Fat-fighting pharma business files for bankruptcy

March 15, 2018
Sales and Marketing Contrave, biotech, drugs, orexigen, pharma, pharmaceutical

Orexigen Therapeutics, a biotech that was one of a wave of companies bringing through weight-loss pills, has announced that it …

News

Andrew Witty takes on a new CEO position

March 15, 2018
Medical Communications Andrew Witty, GSK, Optum, UnitedHealth, biotech, drugs, pharma, pharmaceutical

Andrew Witty, who made his name working his way up the ranks at GSK to become its CEO, has revealed …

News
veeva_event

Top 5 Reasons Why You Should Attend Veeva R&D Summit, Europe

March 15, 2018
Medical Communications biotech, drugs, pharma, pharmaceutical, veeva

Veeva R&D Summit, Europe is an annual gathering of pharma, biotech and medical devices professionals in clinical, regulatory, quality, and …

News
saroukos

Takeda’s CFO departs forcing company to act

March 14, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, biotech, drugs, pharma, pharmaceutical

Takeda has announced that its Chief Financial Officer, James Kehoe, has decided to move on from the company to take …

Appointment
teva_copy

Teva denies wrongdoing in Cephalon pay-to-delay deal hearing

March 14, 2018
Research and Development, Sales and Marketing Cephalon, Pay to delay, Provogil, Teva, pay-to-delay, pharma

Teva has denied allegations from the European Commission (EC) that it engaged in illegal anti-competitive pay-to-delay tactics to maintain its …

News
philip_hammond

Hammond suggests NHS may receive cash boost

March 14, 2018
Medical Communications, Research and Development Autumn Budget, NHS, UK, biotech, drugs, pharma, pharmaceutical

The pressures on the NHS over the winter months exposed serious cracks in the service, with issues regarding underfunding, struggles …

News
architect_of_the_capitol

US “right to try” experimental drug bill defeated in House vote

March 14, 2018
Research and Development, Sales and Marketing FDA, House of representatives, Right to try, US, pharma

The divisive and much-talked-about “right to try” legislation designed to provide access for terminally ill Americans to experimental and unproven …

News
pills-384846_960_720

World’s first synthetic, non-biologic vaccine developed

March 14, 2018
Research and Development Vaccine, biotech, drugs, influenza, pharma, pharmaceutical

One of the major challenges in delivering vaccinations to all parts of the globe is the need to keep the …

News
abbvieuse_054_low

AbbVie secures further strong results for potential blockbuster

March 13, 2018
Research and Development AbbVie, biotech, drugs, elagolix, pharma, pharmaceutical

AbbVie’s elagolix has been slated as a blockbuster-in-the-making by analysts predicting big things for the potential treatment for uterine fibroids …

News
biocon-k8tc--621x414livemint

FDA inspection reveals cGMP issues at Biocon’s major Malaysia facility

March 13, 2018
Manufacturing and Production Biocon, CGMP, FDA, pharma

Biocon’s insulin production facility in Johar, Malaysia – the largest integrated insulin manufacturing facility in Asia – has been slapped …

News
fda_building_web

Adaxis-AZ immunotherapy combo hit by clinical hold after death

March 13, 2018
Manufacturing and Production, Research and Development Adaxis, AstraZeneca, Imfinzi, biotech, drugs, immunotherapy, pharma, pharmaceutical

Adaxis and AstraZeneca announced that they had agreed a combination program for axalimogene filolisbac and Imfinzi, respectively, back in 2014 …

News
shutterstock_159488225

Anthera pulls the plug on Sollpura after Phase 3 failure, shares plummet 84%

March 13, 2018
Manufacturing and Production, Research and Development Anthera, Eli Lilly, Sollpura, pharma, trial failure

Anthera Pharmaceuticals has announced that it is to terminate development of its investigational pancreatic enzyme replacement therapy (PERT) Sollpura after …

News
novartis_side_building

Novartis reshuffle begins under new CEO

March 13, 2018
Manufacturing and Production, Medical Communications Novartis, biotech, digital, drugs, pharma, pharmaceutical

It’s a common strategy that newly appointed CEOs will try to change the direction of the company via rejigging leadership …

News
biology-think-networking-physiology-brain-anatomy-2676370

Pfizer begins sell-off, shedding CNS drug to Biogen for $590m

March 13, 2018
Manufacturing and Production, Sales and Marketing Biogen, CNS, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer’s decision to back out of the neuroscience space was a strategic move that send shudders through the entire industry, …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026